The metabolism of phosphatidylinositol 4-phosphate (PtdIns4P) and phosphatidylinositol 4,5-bisphosphate [PtdIns(4,5)P2] in rat parotid acinar cells was investigated, particularly with regard to the effects of receptor-active agonists. Stimulation of cholinergic-muscarinic receptors with methacholine provoked a rapid disappearance of 40-50% of [32P]PtdIns(4,5)P2, but had no effect on PtdIns4P. Adrenaline, acting on a-adrenoceptors, and Substance P also stimulated net loss of Ptdlns(4,5)P2. The fi-adrenoceptor agonist, isoprenaline, and the Ca2+ ionophore, ionomycin, failed to affect labelled PtdIns(4,5)P2 or PtdIns4P. By chelation of extracellular Ca2+ with excess EGTA, and by an experimental protocol that eliminates cellular Ca.+ release, it was demonstrated that the agonist-induced decrease in Ptdlns(4,5)P2 is independent of both Ca2+ influx and Ca2+ release. These results may suggest that net Ptdlns(4,5)P2 breakdown is an early event in the stimulus-response pathway of the parotid acinar cell and could be directly involved in the mechanism of agonist-induced Ca2+ release from the plasma membrane.
Much of the current interest in phosphoinositide metabolism centres around a hypothesis offered by Michell (1975) suggesting that phospholipase Cmediated breakdown of Ptdlns may be involved in the mechanism by which receptor activation is coupled to Ca2+-mobilization (Michell, 1979; Berridge, 1980; . The evidence for this idea stems largely from the striking (and apparently exclusive) association of enhanced PtdIns breakdown with receptors that act by mobilizing Ca2 , together with the demonstration that receptor stimulation of Ptdlns breakdown is itself apparently not a Ca2+-mediated event. The latter point derives from the experimental findings that phospholipase C-mediated Ptdlns breakdown is minimally (or not at all) inhibited by removal of extracellular Ca2+, and is not activated by Ca2+-ionophores (there are exceptions; Cockroft et al., 1980a,b; Fisher & Agranoff, 1980) .
In addition to the breakdown of PtdIns, in some Abbreviations used: Ptdlns, phosphatidylinositol; PtdIns4P, phosphatidylinositol 4-phosphate; Ptdlns-(4,5)P2, phosphatidylinositol 4,5-bisphosphate. systems it has been demonstrated that phosphorylated derivatives of Ptdlns, the polyphosphoinositides, are also broken down in response to receptor activation (Abdel-Latif et al., 1977) . This effect, however, has been shown to be Ca2+-dependent and mimicked by Ca2+-ionophores (Akhtar & AbdelLatif, 1978) , leading to the suggestion that polyphosphoinositide breakdown is probably not involved in the mechhnism of Ca2+-mobilization but rather may be involved in the mechanism(s) by which the cellular responses to Ca2+ are expressed (Akhtar & Abdel-Latif, 1978; .
In a recent study with hepatocytes, Kirk et al. (1981) examined the effects of vasopressin, a Ca2+_ mobilizing hormone, on polyphosphoinositide metabolism. These investigators found that vasopressin caused a rapid breakdown of the polyphosphoinositides; the effect was only partially inhibited by Ca2+ omission. Additionally, the Ca2+-ionophore A23 187 did not activate polyphosphoinositide breakdown. Kirk et al. (1981) suggest that polyphosphoinositide breakdown may be an early event in hepatocyte activation, perhaps preceding Ptdlns breakdown.
In the present study we have examined the effects of agonists on the 32P-labelled polyphosphoinositides, PtdIns4P and Ptdlns(4,5)P2 in the rat parotid acinar cell. The results show that in the parotid gland, net Ptdlns(4,5)P2 breakdown occurs, is a Ca2+-independent response to receptor activation and could therefore play some role in the mechanism of Ca2+-mobilization.
Experimental
Parotid glands were removed from anaesthetized (sodium pentobarbitone) male Sprague-Dawley rats (140-200 g ) and dispersed acinar cells were prepared as previously described . The cells were suspended at a concentration of 1-2mg of protein/ml in a Ringer medium of the following composition (mM); NaCI, 120; KCI, 5.0; MgCI2, 1.2; CaC12, 1.0; Tris, 20; sodium fi-hydroxybutyrate, 5.0; and 0.5% bovine serum albumin. The media were titrated with HCI (about 10mM final Cl-concentration) to a pH of 7.4 at 370C. The gas phase was 100% 02.
Cells were equilibrated with the above medium for 20min, at which time 1Op"M-P32PIPp was added as the neutral sodium salt. The specific radioactivity of the [132PlP was adjusted so that the 10gM concentration provided a radioactivity concentration of about 5,pCi/ml. At various times thereafter drugs were added to the media and portions of the cell suspension were taken for analysis. The portions (0.6 ml) were rapidly homogenized in 2.25 ml of chloroform/methanol (1:2, v/v) + 2.0,ul of 6M-HCI and the phospholipids were extracted by the method of Bligh & Dyer (1959) as modified by Lapetina & Michell (1972) . The PtdIns4P and Ptdlns(4,5)P2 were separated from other radioactive phospholipids by t.l.c. in one dimension as described by Schacht (1978) and visually detected by autoradiography. The method employs 10cm plates coated with 0.25mm silica gel 60 (EM reagents) and a solvent system of chloroform/methanol/aq. NH3/water (90:90:7:20, by vol.) . The spots described by Schacht (1978) 
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When the cholinergic-muscarinic agonist, methacholine, was added to the suspension of cells, rapid (t, < 1 min) disappearance of about 45% of labelled Ptdlns(4,5)P2, but not PtdIns4P, occurred (Fig. 2) . The small increase in PtdIns4P at min was also seen in unstimulated controls (not shown) from which these data did not differ significantly. This may result from a small sampling artifact as it was generally seen in the Ptdlns(4,5)P2 controls as well (Fig. 3, for example) . The apparent time course for loss of radioactivity from Ptdlns(4,5)P2 was identical whether cells were pre-incubated with [32P1P, for 30 or 60min. This suggests that [32P1P, uniformly labels a homogeneous pool of Ptdlns(4,5)P2 (not necessarily total cellular Ptdlns(4,5)P2), and that the percentage change in radioactive Ptdlns(4,5)P2 probably reflects similar net changes in mass for the specific pool of Ptdlns(4,5)P2 labelled under these conditions. For the remaining experiments in vitro, the period of pre-incubation with V32P]P was 60min.
Agents acting on the three known Ca2+-mobilizing receptors in the parotid were compared with respect to their abilities to provoke loss of radioactive Ptdlns(4,5)P2; the results are summarized in Fig. 3 . Adrenaline was used together with 10puM-propranolol to assure activation of only the aadrenoceptor pathway. Of the three agents (methacoline, Substance P, adrenaline with propranolol), methacholine caused the greatest effect. The temporal patterns of radioactivity loss due to methacholine and adrenaline were similar. The pattern for Substance P differed, however, the effect being equal to that for methacholine for the first minute, but the labelled Ptdlns(4,5)P2 subsequently rose such that the net change was, at 5-10min, more similar to the less efficacious adrenaline. None of the three agonists had significant effects on PtdIns4P radioactivity (results not shown).
The f,-adrenoceptor catecholamine, isoprenaline (10uM), and the Ca2+ ionophore, ionomycin (2.677pM), were tested for effects on the polyphosphoinositides. Neither compound significantly affected radioactive PtdIns(4,5)P2 or PtdIns4P (results not shown; less than 5% change), whereas in two concurrent experiments, methacholine caused a decrease similar to the preceding experiments.
The rapidity of the effect of methacholine on Ptdlns(4,5)P2 was examined in experiments shown in Fig. 4 . Analysis of variance showed that PtdIns- The data on PtdIns4P radioactivity from these same experiments are shown in Fig. 6 (note the expanded scale). As before, only minor (and insignificant) changes were observed when agonists were applied, but when atropin was applied after methacholine, a 20-30% increase in PtdIns4P labelling was observed that was statistically significant and roughly paralleled the rise in radioactive Ptdlns-(4,5)P2in Fig. 5 .
To obtain an approximation of the PtdIns (4,5 
Discussion
The rat parotid gland can be activated by any of four known receptor pathways: fJ-adrenergic, a-adrenergic, muscarinic (cholinergic) and substance P (Schramm & Selinger, 1975; . The JJ-adrenoceptor pathway primarily regulates protein secretion utilizing cyclic AMP as second messenger. The other three pathways (muscarinic, a-adrenergic, Substance P) primarily regulate univalent ion fluxes, which may be involved in secretion of water and electrolytes; apparently Ca2+ serves as second messenger for these effects . Further, the evidence suggests that these three receptors in the parotid (and probably elsewhere) mobilize Ca2+ by two mechanisms: an enhancement of Ca2+ influx (increased membrane permeability to Ca2+) and release of bound or sequestered Ca2+ from some cellular store . Indirect evidence suggests that the releasable pool of cellular Ca2+ may reside in the plasma membrane . The data obtained in this investigation suggest that breakdown of a specific pool of Ptdlns(4,5)P2 could Vol. 206 play a role in the mechanism by which receptor activation effects Ca2+-mobilization. The arguments are similar to those developed originally by Michell (1975 Michell ( , 1979 , suggesting such a role for PtdIns breakdown. The data in Fig. 3 show that this reaction is activated by receptors involved in Ca2+-mobilization. However, the effect cannot be provoked through the /3-adrenergic receptor, which acts through cyclic AMP. Despite this association with the Ca2+ pathway, the data also clearly show that Ptdlns(4,5)P2 loss is not a consequence of Ca2+-mobilization. For example, ionomycin, a Ca2+-ionophore, failed to stimulate Ptd1ns(4,5)P2 breakdown.
Previous studies have shown that this concentration of ionomycin (2.67pM) under these experimental conditions provokes Ca2+-mobilization and Ca2+-mediated responses of a magnitude similar to those obtained with muscarinic agonists .
The addition to the cell suspension of EGTA in concentrations sufficient to decrease external [Ca2+1 to less than 1,UM failed to affect the Ptdlns(4,5)P2 breakdown response to methacholine (Fig. 5) . However, the possibility exists that receptor-mediated intracellular Ca2+ release known to occur in Ca2+-deficient media (Haddas et al., 1979) could be acting as catalyst for the Ptdlns(4,5)P2 effect. This possibility is effectively ruled out by the ability of Substance P to cause Ptdlns(4,5)P2 breakdown in the Ca2+-deficient medium. It has previously been shown that this experimental sequence, i.e.. muscarinic agonist followed by muscarinic antagonist followed by Substance P, results in a failure of Ca2+ release by Substance P due to the prior depletion of the relevant Ca2+ pool by the cholinergic agonist (Putney, 1977; Haddas et al., 1979; (Michell, 1975) (Fig. 4) . Also, the time course of Ptdlns(4,5)P2 breakdown, being essentially complete in 2 min, is consistent with the time course of net 45Ca2+ release . As the polyphosphoinositides are known to bind Ca2+ well (Dawson & Hauser, 1979) , it is tempting to speculate that Ca2+-release could arise directly from the breakdown of a PtdIns(4,5)P2-Ca2+ complex. Consistent with this idea is the generally held view that the polyphosphoinositides may be localized in the plasma membrane (Michell, 1975) , which is believed to be the site of receptor-activated Ca2+-release . Studies on the subcellular distribution of the polyphosphoinositides in the parotid gland have not been carried out, however. The roughly estimated Ptdlns(4,5)P2 content of 0.6 nmol/mg of protein would suggest a breakdown in the range of about 0.3nmol/mg of protein if all of the cellular Ptdlns-(4,5)P2 were labelled equally with [32P1Pi. Estimates of the quantity of Ca2+ released after receptor activation are in the range 0.2-0.5 nmol/mg of protein (calculated from data in . Although there is not sufficient data as yet for rigorous quantitative comparison of these parameters, this treatment does show that one estimate of the small quantity of Ptdlns(4,5)P2 lost may at least be in the range anticipated for Ca2+ release.
It is not possible from these data to suggest a specific pathway for loss of Ptdlns(4,5)P2. The term breakdown seems tentatively justified only in the absence of known synthetic pathways utilizing PtdIns(4,5)P2. Reversal of, or decrease in, synthesis of PtdIns(4,5)P2, for example by stimulation of a Ptdlns(4,5)P2 phosphomonoesterase or inhibition of PtdIns4P kinase seems unlikely (but not disproven) since PtdIns4P radioactivity is unaltered. This also argues against a secondary effect on PtdIns(4,5)P2 after Ptdlns breakdown, i.e., by decreasing one of the substrates for PtdIns(4,5)P2 synthesis. It also effectively rules out effects secondary to changes in labelled ATP. In fact, since PtdIns4P is the only known intermediate linking Ptdlns and Ptdlns(4,5)P2, there is no readily apparent connection between the observed receptor-mediated breakdown of these two inositides, and we must tentatively consider the possibility that they represent distinct pathways. Since resynthesis of PtdIns(4,5)P2 after atropine treatment (Fig. 5 ) was associated with a small increase in PtdIns4P, the route of synthesis could involve the previously described sequential phosphorylation of PtdIns (Michell, 1975) . Other tissues have been shown to contain Ptdlns(4,5)P2 phosphodiesterase activity, which could be the pathway involved (Akhtar & Abdel-Latif, 1980; . Until breakdown products are identified, however, other mechanisms remain as possibilities. Hopefully, continued research in this area will more clearly define these pathways. and extend our understanding of the roles of phosphoinositide metabolism in mechanisms of Ca2+-mobilization.
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